U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
grisnilimab [INN]
Preferred Name English
GRISNILIMAB
INN  
Official Name English
IMMUNOGLOBULIN G2A-LAMBDA, ANTI-(CD7 (CD7 ANTIGEN (P41),GP40, LEU-9, TP41, TP40)), MUS MUSCULUSMONOCLONAL ANTIBOD (GRISNILIMAB)
Common Name English
IMMUNOGLOBULIN G2A, ANTI-(HUMAN CD7 ANTIGEN) (MUS MUSCULUS MONOCLONAL WT1 .GAMMA.2A-CHAIN), DISULFIDE WITH MUS MUSCULUS MONOCLONAL WT1 .LAMBDA.-CHAIN, DIMER
Common Name English
Code System Code Type Description
CAS
2367001-70-3
Created by admin on Wed Apr 02 07:20:25 GMT 2025 , Edited by admin on Wed Apr 02 07:20:25 GMT 2025
PRIMARY
NCI_THESAURUS
C175792
Created by admin on Wed Apr 02 07:20:25 GMT 2025 , Edited by admin on Wed Apr 02 07:20:25 GMT 2025
PRIMARY
SMS_ID
100000184305
Created by admin on Wed Apr 02 07:20:25 GMT 2025 , Edited by admin on Wed Apr 02 07:20:25 GMT 2025
PRIMARY
INN
11509
Created by admin on Wed Apr 02 07:20:25 GMT 2025 , Edited by admin on Wed Apr 02 07:20:25 GMT 2025
PRIMARY
FDA UNII
5ADI68Z0PC
Created by admin on Wed Apr 02 07:20:25 GMT 2025 , Edited by admin on Wed Apr 02 07:20:25 GMT 2025
PRIMARY
ACTIVE MOIETY
GRISNILIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966